David Townsend, co-inventor of the PET-CT, visited MEDICIS
The Belgian Nuclear Research Centre SCK CEN seeks to fill a permanent researcher position within the MYRRHA project, as ISOL physicist. Application deadline 10 Sept 23 . Informal contact can be made to Lucia Popescu.
MEDICIS recent achievements have been presented during invited presentations at the ARIS2023 conference (Avignon, France) and the 16th conference on nuclear reaction mechanisms (Varenna, Italy)
Recent technical developments such as the online activity monitoring during implantation and the definition of Key Performance Indicators for MEDICIS were reported at EMIS2022 and IPAC2023 conferences. Related EMIS and IPAC publications.
Three new project proposals were submitted at the 10th MEDICIS Collaboration board, with a notable request to translate one of the MEDICIS High Molar Activity radionuclides in a clinical settings.
The Frontiers Research Topics : MEDICIS-Promed, Advances in Radioactive Ion Beams for Nuclear Medicine is now published. It can be downloaded from there.
The half-life of Tb-155 produced at MEDICIS has been revised and is now published by S. Collins et al. in Applied Radiation and Isotope. High molar activity Sm-153 was 1st used in Targeted Radionuclide Therapy and theranostics (MED-025) by M. Ooms et al, as presented at TERACHEM.
A third collaboration meeting took place today in the French ANR project REPARE, to review the progresses on the development of a high power Bi target for the production of At-211.
1st projects have been selected in PRISMAP-The European medical isotope programme.
Plenary presentation on new developments exploiting isotope mass separation in nuclear medicine presented at the 1st AccConf'22 at IAEA.
MEDICIS restarts its program today. Mass separation will be applied to purify and separate Sm-153 from a target produced at BR2. Some details on the project here.
World cancer day: webinar at 11:30 on MEDICIS mass separation and its impact on theranostics here.
The 1st call for user projects of PRISMAP is launched! More information here.
PRISMAP-The European medical radionuclides programme sets out to substantially change the European landscape for novel and emerging medical radionuclides. More information here.
The article "CERN-MEDICIS: a review since commissioning in 2017" is now published! More information here.
Pr. Thomas Cocolios (KU Leuven) receives the "Roger Van Geen" chair! More information here.
We are welcoming Edgars Mamis from Latvia University, one of the few first PhD students from Latvia at CERN.
CERN-courrier article: MEDICIS shows its stength - More information there.
PRISMAP-The European medical isotope programme has been selected ! More information there
We have received about 30 proposed contributions for our PRISMAP-related Frontiers Research Topical issue! More information there
MEDICIS took part in the CERN Women In Technology photo session. More information here.
Our PRISMAP-related Frontiers Research Topical issue is open for your submissions until 1st November! More information there
PhD defense of Simon Stegemann "Production of mass separated 11-C beams for PET-aided hadron therapy"
Presentation of MEDICIS at the PINSTECH-CERN collaboration conference.
Lecture on medical isotopes, CERN-MEDICIS and PRISMAP-the European medical isotope programme at International Nathiagali Summer College
Record separation efficiencies have been achieved for the first delivery of high specific activity Sm-153 for the high priority MED-025 project !
MEDICIS is ready to restart with radioactive beams !
MEDICIS is re-starting after the Covid outbreak!
PRISMAP: The European medical isotope programme , a consortium with the principal medical radionuclides providers - including MEDICIS - was submitted yesterday for funding by the European Commission; feedback expected after the summer.
CERN-MEDICIS is put in stand-by due to the Covid-19 sanitary crisis.
CERN-MEDICIS restarts with its commissionning phase after two months of technical stop. First stable beam is extracted on the 11th of March !
Pinelopi CHRISTODOULOU from the ERASMUS-Mundus program joins the MEDICIS team to work on her master thesis. She will be working on the implementation of an in-situ gamma-spectrometry system for the characterization of non-conventional radionuclides for medical research.
Do not miss the past news and consult our archives here